| 标题 |
Discovery and Development of a Highly Potent, Orally Bioavailable Estrogen Receptor Full Antagonist and Degrader: Giredestrant (GDC-9545) for Estrogen Receptor-Positive Breast Cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry. Volume 4 作者:Jun Liang; Jie Xu 出版日期:2022 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)